title: Ibrutinib (imbruvica): a novel targeted therapy for chronic lymphocytic leukemia.
abstract: Ibrutinib (Imbruvica): a novel targeted therapy for chronic lymphocytic leukemia.
authors.forename: Sapna
authors.initials: S
authors.lastname: Parmar
authors.forename: Khilna
authors.initials: K
authors.lastname: Patel
authors.forename: Javier
authors.initials: J
authors.lastname: Pinilla-Ibarz
references.citation: J Clin Oncol. 2013 Jan 1;31(1):88-94
references.pmid: 23045577
references.citation: Clin Lymphoma Myeloma. 2009;9 Suppl 3:S194-7
references.pmid: 19778840
references.citation: Br Med Bull. 2008;87:49-62
references.pmid: 18755702
references.citation: Hematology Am Soc Hematol Educ Program. 2004;:163-83
references.pmid: 15561682
references.citation: J Hematol Oncol. 2013 Aug 19;6:59
references.pmid: 23958373
references.citation: Immunol Res. 2001;23(2-3):147-56
references.pmid: 11444380
references.citation: Blood. 2011 Jun 9;117(23):6287-96
references.pmid: 21422473
references.citation: Br J Haematol. 2013 Nov;163(4):436-43
references.pmid: 24111579
references.citation: CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29
references.pmid: 24399786
references.citation: N Engl J Med. 2013 Jul 4;369(1):32-42
references.pmid: 23782158
references.citation: Pharmacotherapy. 2014 Mar;34(3):303-14
references.pmid: 24338680
references.citation: Blood. 2010 Jan 14;115(2):187-97
references.pmid: 19850738
references.citation: Blood. 2008 Jun 15;111(12):5446-56
references.pmid: 18216293
references.citation: Trends Immunol. 2013 Dec;34(12):592-601
references.pmid: 23928062
references.citation: Core Evid. 2013;8:37-45
references.pmid: 23717217